AR107441A1 - Forma cristalina de cobicistat - Google Patents
Forma cristalina de cobicistatInfo
- Publication number
- AR107441A1 AR107441A1 ARP170100170A ARP170100170A AR107441A1 AR 107441 A1 AR107441 A1 AR 107441A1 AR P170100170 A ARP170100170 A AR P170100170A AR P170100170 A ARP170100170 A AR P170100170A AR 107441 A1 AR107441 A1 AR 107441A1
- Authority
- AR
- Argentina
- Prior art keywords
- cobicistat
- crystal form
- crystalline form
- drxp
- peaks
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Reivindicación 1: Una forma cristalina de un compuesto de fórmula (1). Reivindicación 2: Forma cristalina de la reivindicación 1, caracterizada por un patrón de difracción de rayos X en polvo (DRXP) que comprende picos a 17.2 ± 0.2 y 19.6 ± 0.2 (radiación de Cu Ka, expresada en grados 2q).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662288029P | 2016-01-28 | 2016-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR107441A1 true AR107441A1 (es) | 2018-05-02 |
Family
ID=57966186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170100170A AR107441A1 (es) | 2016-01-28 | 2017-01-23 | Forma cristalina de cobicistat |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20170217952A1 (es) |
| EP (1) | EP3408261A1 (es) |
| JP (1) | JP2019508393A (es) |
| KR (1) | KR20180101589A (es) |
| CN (1) | CN108834413A (es) |
| AR (1) | AR107441A1 (es) |
| AU (2) | AU2017211118B2 (es) |
| BR (1) | BR112018014643A2 (es) |
| CA (1) | CA3011930A1 (es) |
| EA (1) | EA201891447A1 (es) |
| MA (1) | MA46513A (es) |
| MX (1) | MX2018009056A (es) |
| SG (1) | SG11201806109RA (es) |
| TW (1) | TW201728582A (es) |
| WO (1) | WO2017132158A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE026380T2 (en) | 2008-05-02 | 2016-06-28 | Gilead Sciences Inc | Use of solid carrier particle |
| CN109384739B (zh) * | 2017-08-14 | 2023-06-02 | 上海奥博生物医药股份有限公司 | 一种可比司他新晶型及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02258B (me) | 2006-07-07 | 2015-12-31 | Gilead Sciences Inc | Modulatori farmakokinetičkih svojstava terapeutika |
| HUE026380T2 (en) * | 2008-05-02 | 2016-06-28 | Gilead Sciences Inc | Use of solid carrier particle |
| WO2012151165A1 (en) * | 2011-05-02 | 2012-11-08 | Gilead Sciences, Inc. | Amorphous solid salts |
-
2017
- 2017-01-18 TW TW106101624A patent/TW201728582A/zh unknown
- 2017-01-23 AR ARP170100170A patent/AR107441A1/es unknown
- 2017-01-24 CA CA3011930A patent/CA3011930A1/en not_active Abandoned
- 2017-01-24 CN CN201780015117.9A patent/CN108834413A/zh active Pending
- 2017-01-24 US US15/414,438 patent/US20170217952A1/en not_active Abandoned
- 2017-01-24 WO PCT/US2017/014761 patent/WO2017132158A1/en active Application Filing
- 2017-01-24 KR KR1020187024280A patent/KR20180101589A/ko not_active Application Discontinuation
- 2017-01-24 EP EP17703588.8A patent/EP3408261A1/en not_active Withdrawn
- 2017-01-24 SG SG11201806109RA patent/SG11201806109RA/en unknown
- 2017-01-24 EA EA201891447A patent/EA201891447A1/ru unknown
- 2017-01-24 BR BR112018014643A patent/BR112018014643A2/pt not_active Application Discontinuation
- 2017-01-24 MX MX2018009056A patent/MX2018009056A/es unknown
- 2017-01-24 AU AU2017211118A patent/AU2017211118B2/en active Active
- 2017-01-24 JP JP2018539079A patent/JP2019508393A/ja active Pending
- 2017-01-24 MA MA046513A patent/MA46513A/fr unknown
-
2019
- 2019-12-17 AU AU2019283825A patent/AU2019283825A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017211118B2 (en) | 2020-01-16 |
| MA46513A (fr) | 2019-08-21 |
| US20170217952A1 (en) | 2017-08-03 |
| JP2019508393A (ja) | 2019-03-28 |
| SG11201806109RA (en) | 2018-08-30 |
| MX2018009056A (es) | 2018-11-19 |
| EA201891447A1 (ru) | 2019-03-29 |
| CA3011930A1 (en) | 2017-08-03 |
| TW201728582A (zh) | 2017-08-16 |
| WO2017132158A1 (en) | 2017-08-03 |
| BR112018014643A2 (pt) | 2018-12-11 |
| CN108834413A (zh) | 2018-11-16 |
| EP3408261A1 (en) | 2018-12-05 |
| AU2019283825A1 (en) | 2020-01-16 |
| AU2017211118A1 (en) | 2018-08-09 |
| KR20180101589A (ko) | 2018-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20201444A1 (es) | Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido | |
| AR129504A2 (es) | Hidrato de diclorhidrato de omecamtiv mecarbil, formas cristalinas, y composiciones farmacéuticas | |
| AR103444A1 (es) | Forma cristalina de un derivado de bencimidazol y un método de preparación de los mismos | |
| MY180083A (en) | Tetrahydropyrrolothiazine compounds | |
| MX2016007522A (es) | Estimuladores de guanilato ciclasa soluble (sgc). | |
| WO2017075629A3 (en) | Wee 1 kinase inhibitors and methods of making and using the same | |
| DK201470447A (en) | Crystal of flumioxazin | |
| MX2015015130A (es) | Compuestos de biheteroarilo y usos de los mismos. | |
| HRP20211670T1 (hr) | Derivat difenilmetana u kristalnom obliku | |
| GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
| PE20141061A1 (es) | Compuesto inhibidor de la senalizacion de la trayectoria notch | |
| NZ743374A (en) | Crystalline forms of diazabicyclooctane derivative and production process thereof | |
| CR20110457A (es) | Nueva forma cristalina vi de la agomelatina, preparacion y uso de la misma | |
| AR095435A1 (es) | Formas salinas del (2-(2-(4-fluorofenil)tiazol-4-il)propan-2-il)carbamato de (s)-quinuclidin-3-ilo | |
| PH12018500903A1 (en) | Pyranodipyridine compound | |
| EP3493921A4 (en) | ROLL-TO-ROLL PROGRAMMABLE FILM IMPRESSION LITHOGRAPHY | |
| PH12015502122A1 (en) | Sovaprevir polymorphs and methods of manufacturing thereof | |
| AR107441A1 (es) | Forma cristalina de cobicistat | |
| AR108257A1 (es) | Formas polimórficas de 3-[2-butil-1-(2-dietilamino-etil)-1h-bencimidazol-5-il]-n-hidroxi-acrilamida y usos de las mismas | |
| AR082435A1 (es) | Valsartan altamente cristalino | |
| AR112842A1 (es) | Cristal de pirazina | |
| ES2489467T3 (es) | Polimorfo novedoso del clorhidrato del éster (6-dimetilaminometil-2-naftalenílico) del ácido (4-hidroxicarbamoilfenil)-carbámico | |
| AR099082A1 (es) | Formas sólidas de tenofovir | |
| MX368316B (es) | Sales de clorhidrato de aluminio que exhiben un pico 1 sec alto. | |
| AR095346A1 (es) | Compuesto de hidrato de fluoreno y sus cristales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |